COST

975.98

-0.18%↓

156.8

+0.93%↑

65.16

+1.64%↑

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

156.8

+0.93%↑

65.16

+1.64%↑

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

156.8

+0.93%↑

65.16

+1.64%↑

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

156.8

+0.93%↑

65.16

+1.64%↑

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

156.8

+0.93%↑

65.16

+1.64%↑

94.31

+1.29%↑

SYY

84.63

+0.01%↑

Home・Akciju saraksts・USANA Health Sciences Inc

USANA Health Sciences Inc

Slēgts

20.78 2.26

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

20.32

Max

20.97

Galvenie mērījumi
By Trading Economics
Ienākumi	-17M -6.7M
Pārdošana	-22M 214M
P/E Sektora vidējais	24.067 29.995
EPS	-0.15
Peļņas marža	-3.118
Darbinieki	1,700
EBITDA	-17M 11M

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 17. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	14M 396M
Iepriekšējā atvēršanas cena	18.52
Iepriekšējā slēgšanas cena	20.78

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

28.405 / 29.84 Atbalsts un pretestība

USANA Health Sciences Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 5. febr. 00:00 UTC

Karstas akcijas

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

2026. g. 4. febr. 22:55 UTC

Peļņas

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

2026. g. 4. febr. 21:44 UTC

Peļņas

Arm Holdings 3Q Profit Falls Despite Revenue Growth

2026. g. 4. febr. 21:39 UTC

Peļņas

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

2026. g. 5. febr. 00:00 UTC

Peļņas

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

2026. g. 5. febr. 00:00 UTC

Peļņas

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

2026. g. 4. febr. 23:46 UTC

Tirgus saruna

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

2026. g. 4. febr. 23:45 UTC

Peļņas

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

2026. g. 4. febr. 23:32 UTC

Tirgus saruna

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

2026. g. 4. febr. 22:59 UTC

Iegādes, apvienošanās, pārņemšana

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

2026. g. 4. febr. 22:30 UTC

Peļņas

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

2026. g. 4. febr. 22:30 UTC

Peļņas

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

2026. g. 4. febr. 22:21 UTC

Peļņas

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026. g. 4. febr. 22:17 UTC

Tirgus saruna

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

2026. g. 4. febr. 22:15 UTC

Tirgus saruna

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

2026. g. 4. febr. 22:00 UTC

Tirgus saruna

ESG Roundup: Market Talk

2026. g. 4. febr. 21:53 UTC

Peļņas

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

2026. g. 4. febr. 21:51 UTC

Peļņas

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026. g. 4. febr. 21:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 4. febr. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Financial Services Roundup: Market Talk

2026. g. 4. febr. 21:50 UTC

Tirgus saruna

Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 4. febr. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 4. febr. 21:45 UTC

Peļņas

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

2026. g. 4. febr. 21:44 UTC

Peļņas

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

2026. g. 4. febr. 21:43 UTC

Peļņas

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

2026. g. 4. febr. 21:41 UTC

Peļņas

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

2026. g. 4. febr. 21:36 UTC

Tirgus saruna

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

2026. g. 4. febr. 21:30 UTC

Peļņas

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026. g. 4. febr. 21:30 UTC

Peļņas

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026. g. 4. febr. 21:30 UTC

Peļņas

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Salīdzinājums

Cenas izmaiņa

USANA Health Sciences Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam USANA Health Sciences Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

28.405 / 29.84Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.